Loading...
Environmental Risk Assessment of Recombinant Viral Vector Vaccines against SARS-Cov-2
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the coronavirus disease 2019 (COVID-19) pandemic. Over the past months, considerable efforts have been put into developing effective and safe drugs and vaccines against SARS-CoV-2. Various platforms are being used...
Na minha lista:
| Udgivet i: | Vaccines (Basel) |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8147846/ https://ncbi.nlm.nih.gov/pubmed/34063733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines9050453 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|